Tolley Health Economics Ltd

At Tolley Health Economics, we specialise in all aspects of bespoke Health Technology Assessment (HTA) to the pharmaceutical industry, culminating in patients gaining access to treatments. Since 2008, our mission has been to use our wealth of experience from academia, pharma, and consultancy to be the preferred partner of the pharma companies we work with. Set up in 2008 by Keith Tolley and Dr Amanda Strickson, Tolley Health Economics (THE) are now a small and focussed team of 14, comprising health economists, medical writers, and executive support staff that produces high quality (publishable) HTA-related activities. We offer a decision-focused approach...

Uk hta submissions, health economics,medical writing,systematic literature reviews,structured expert elicitation,indirect treatment comparisons,utility studies,multi-stakeholder panels,economic modelling,budget impact analysis,network meta-analysis,market access,manuscripts,nice,smc,awmsg,ncpe,cost and resource use studies,early scientific advice,and briefing books

Tolley health economics ltd operates in the Pharmaceutical manufacturing industry.

Tolley health economics ltd's revenue is 11m - 100m

Tolley health economics ltd has 11 - 50 employees.